A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The study has an open-label, randomized, crossover design, in which each subject will receive
mannitol powder for inhalation using a dry powder inhaler with and without premedication with
a bronchodilator, mannitol powder for inhalation in capsules administered orally, and
mannitol in a commercial formulation designed for intravenous use.